❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Microbiology ❭ Genome instability in ageing and disease [Nilsen] ❭ Clinical trials ❭

Clinical trials:

NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia

  • Link to home page at ClinicalTrials.gov
  • Hilde Loge Nilsen PI

Collaborator in:

  • NO-PARK studien (helse-bergen.no)
  • NO-ALS (NeuroSysMed.no)
  • NARNIA 
 
Scroll to top

Home Dept. of Microbiology Genome instability in ageing and disease [Nilsen]

  • Group members
  • Current projects
  • Clinical trials
  • Publications

Recent publications

Arczewska KD, Sys D, Nilsen HL, Piekiełko-Witkowska A (2026)
DNA Damage and Repair in Thyroid Physiology and Disease
Endocr Rev, 47 (1), 121-157
DOI 10.1210/endrev/bnaf035, PubMed 41054930

Følling I, Selle ML, Nilsen HR, Wennerström AB, Nilsen HL, Eide TJ (2026)
Distribution of glucagon-like peptide 1 receptor and insulin in phaeochromocytomas
Endocr Connect, 15 (1)
DOI 10.1530/EC-25-0338, PubMed 41488993

Lagartos-Donate MJ, Escobar-Doncel B, Zhang SQ, Pan JP, Villaseca González N, Anisimov A, Montaldo NP, Jensen V, Mao L, Li B, Banzon-Pereira N, Shi L, Cao SQ, Caponio D, Wang P, Nair RR, Luo OJ, Chen G, Nevado-Holgado AJ, Buckley N, Nilsen HL, Fang EF (2026)
Loss of REST associated with Alzheimer's disease pathology is ameliorated by NAD
Brain (in press)
DOI 10.1093/brain/awaf261, PubMed 41709697

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)